Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program
IntroductionThe IraPEN program is an adapted version of the WHO-PEN program designed to prevent four major non-communicable diseases in Iran. This study aimed to determine the rate of compliance and related factors among individuals participating in the IraPEN program for the prevention of cardiovas...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1098312/full |
_version_ | 1827809128257421312 |
---|---|
author | Fatemeh Hadavandsiri Davood Khalili Alireza Mahdavi Mehdi Afkar Afshin Ostovar Seyed-Saeed Hashemi-Nazari Somayeh Derakhshan |
author_facet | Fatemeh Hadavandsiri Davood Khalili Alireza Mahdavi Mehdi Afkar Afshin Ostovar Seyed-Saeed Hashemi-Nazari Somayeh Derakhshan |
author_sort | Fatemeh Hadavandsiri |
collection | DOAJ |
description | IntroductionThe IraPEN program is an adapted version of the WHO-PEN program designed to prevent four major non-communicable diseases in Iran. This study aimed to determine the rate of compliance and related factors among individuals participating in the IraPEN program for the prevention of cardiovascular disease.MethodIn this study, compliance was defined as timely referral to the health center as scheduled, and the researchers approached four pilot sites of IraPEN from March 2016 to March 2018. Sex-stratified logistic regressions were applied to investigate factors related to compliance. However, it is important to note that in this study, compliance was defined as compliance to revisit, not compliance to taking prescribed medications or behavioral lifestyle changes.ResultsThe total compliance rate, including timely compliance and early and late compliance, was 16.5% in men and 23.3% in women. The study found that cardiovascular risk factors such as diabetes, hypertension, hypercholesterolemia, and being underweight were associated with lower compliance. The higher calculated risk of CVD was associated with higher compliance, but after adjusting for cardiovascular risk factors, high-risk individuals showed lower compliance. There was negligible interaction between sex and other factors for compliance.ConclusionThe compliance rate with scheduled programs for cardiovascular preventive strategies was very low, and high-risk individuals were less compliant, regardless of their high level of risk factors. The study recommends further training to increase awareness and knowledge regarding the IraPEN program and the prevention of non-communicable diseases among high-risk populations. |
first_indexed | 2024-03-11T22:38:37Z |
format | Article |
id | doaj.art-38532afa5b3742ccbc1dd9b5d1c0de4a |
institution | Directory Open Access Journal |
issn | 2296-2565 |
language | English |
last_indexed | 2024-03-11T22:38:37Z |
publishDate | 2023-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Public Health |
spelling | doaj.art-38532afa5b3742ccbc1dd9b5d1c0de4a2023-09-22T09:35:02ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-09-011110.3389/fpubh.2023.10983121098312Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national programFatemeh Hadavandsiri0Davood Khalili1Alireza Mahdavi2Mehdi Afkar3Afshin Ostovar4Seyed-Saeed Hashemi-Nazari5Somayeh Derakhshan6School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, IranPrevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IranCenter for Noncommunicable Disease Control and Prevention, Ministry of Health (MOH), Tehran, IranCommunity Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, IranOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranPrevention of Cardiovascular Disease Research Center, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, IranSchool of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, IranIntroductionThe IraPEN program is an adapted version of the WHO-PEN program designed to prevent four major non-communicable diseases in Iran. This study aimed to determine the rate of compliance and related factors among individuals participating in the IraPEN program for the prevention of cardiovascular disease.MethodIn this study, compliance was defined as timely referral to the health center as scheduled, and the researchers approached four pilot sites of IraPEN from March 2016 to March 2018. Sex-stratified logistic regressions were applied to investigate factors related to compliance. However, it is important to note that in this study, compliance was defined as compliance to revisit, not compliance to taking prescribed medications or behavioral lifestyle changes.ResultsThe total compliance rate, including timely compliance and early and late compliance, was 16.5% in men and 23.3% in women. The study found that cardiovascular risk factors such as diabetes, hypertension, hypercholesterolemia, and being underweight were associated with lower compliance. The higher calculated risk of CVD was associated with higher compliance, but after adjusting for cardiovascular risk factors, high-risk individuals showed lower compliance. There was negligible interaction between sex and other factors for compliance.ConclusionThe compliance rate with scheduled programs for cardiovascular preventive strategies was very low, and high-risk individuals were less compliant, regardless of their high level of risk factors. The study recommends further training to increase awareness and knowledge regarding the IraPEN program and the prevention of non-communicable diseases among high-risk populations.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1098312/fullcomplianceWHO-PENIraPENrelative factorscardiovascular diseaserisk |
spellingShingle | Fatemeh Hadavandsiri Davood Khalili Alireza Mahdavi Mehdi Afkar Afshin Ostovar Seyed-Saeed Hashemi-Nazari Somayeh Derakhshan Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program Frontiers in Public Health compliance WHO-PEN IraPEN relative factors cardiovascular disease risk |
title | Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program |
title_full | Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program |
title_fullStr | Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program |
title_full_unstemmed | Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program |
title_short | Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program |
title_sort | timely referral to health centers for the prevention of cardiovascular diseases irapen national program |
topic | compliance WHO-PEN IraPEN relative factors cardiovascular disease risk |
url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1098312/full |
work_keys_str_mv | AT fatemehhadavandsiri timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT davoodkhalili timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT alirezamahdavi timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT mehdiafkar timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT afshinostovar timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT seyedsaeedhasheminazari timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram AT somayehderakhshan timelyreferraltohealthcentersforthepreventionofcardiovasculardiseasesirapennationalprogram |